Progressive respiratory failure is seen as a major cause of death in severe acute respiratory
syndrome coronavirus 2 (SARS-Cov-2)-induced infection. Relatively little is known about the …

To reveal if coagulopathies relate to the course of COVID-19, we examined 255 patients with
moderate and severe COVID-19, receiving anticoagulants and immunosuppressive drugs …

COVID-19 infection is associated with a broad spectrum of presentations, but alveolar
capillary microthrombi have been described as a common finding in COVID-19 patients …

Platelet–endothelial interactions have a critical role in microcirculatory function, which
maintains tissue homeostasis. The subtle equilibrium between platelets and the vessel wall …

Although the precise pathogenesis of coronavirus disease 2019 (COVID-19) currently
remains unknown, its complex nature is gradually being revealed. COVID-19 is a disease …

Abnormal coagulation dynamics, including disseminated intravascular coagulopathy,
pulmonary embolism, venous thromboembolism and risk of thrombosis are often associated …

Abstract Coronavirus disease 2019 (COVID-19) is still an ongoing pandemic worldwide.
COVID-19 is an age-related disease with a higher risk of organ dysfunction and mortality in …

Introduction COVID-19 is associated to an increased risk of thrombosis, as a result of a
complex process that involves the activation of vascular and circulating cells, the release of …

Abstract Coronavirus disease 2019 (COVID-19) causes a spectrum of disease; some
patients develop a severe proinflammatory state which can be associated with a unique …

Objective: Pulmonary thrombosis is observed in severe acute respiratory syndrome
coronavirus 2 pneumonia. Aim was to investigate whether subpopulations of platelets were …